Metabolism of Augmentin and Cephalosporins
Augmentin (amoxicillin/clavulanate) is primarily metabolized by the liver, while most cephalosporins are predominantly excreted unchanged by the kidneys with minimal hepatic metabolism.
Augmentin (Amoxicillin/Clavulanate) Metabolism
Amoxicillin itself undergoes minimal hepatic metabolism and is primarily excreted unchanged by the kidneys 1. However, clavulanic acid (the β-lactamase inhibitor component) is primarily metabolized by the liver through hepatic metabolism 2. This dual pathway is clinically important:
- Amoxicillin can be used safely in patients with renal impairment when dosed appropriately 3
- The hepatic metabolism of clavulanic acid means the combination requires caution in patients with hepatic dysfunction 4
- Hepatic toxicity associated with amoxicillin/clavulanate is usually reversible but has been reported, particularly in elderly males or those on prolonged treatment 4
Clinical Implications for Augmentin
The FDA drug label explicitly warns that Augmentin should be used with caution in patients with evidence of hepatic dysfunction 4. Hepatic dysfunction may occur during or several weeks after therapy discontinuation, though it is usually reversible 4. The liver-related adverse effects are attributed primarily to the clavulanic acid component, which undergoes hepatic metabolism and is more strongly associated with gastrointestinal side effects than amoxicillin alone 2.
Cephalosporin Metabolism
Most cephalosporins are NOT significantly metabolized by the liver and are instead excreted renally in unchanged form 5. However, there are notable exceptions:
Cephalosporins with Hepatic Excretion/Metabolism:
- Ceftriaxone: Up to 30% biliary excretion, allowing use without dose adjustment in renal insufficiency 5
- Cefoperazone: Up to 30% biliary excretion 5
- Cefotaxime: Undergoes significant metabolism to active metabolites 5
- Cefalotin and cefacetril: Metabolized to a significant degree 5
Cephalosporins Requiring Renal Dose Adjustment:
The majority of cephalosporins listed in guidelines require no hepatic dose adjustment but DO require renal dose adjustment 6, 7:
- Cefdinir: Not appreciably metabolized, eliminated principally via renal excretion 6
- Cefuroxime, cefpodoxime, cefixime, cefprozil: Primarily renal excretion 6
- First and second-generation cephalosporins generally follow renal excretion patterns 7
Key Clinical Point:
For patients with renal insufficiency (creatinine clearance <30 mL/min), dose reduction is NOT necessary for cefoperazone and ceftriaxone due to hepatic excretion, and for cefotaxime due to metabolism 5. All other cephalosporins typically require renal dose adjustment.
Practical Algorithm for Prescribing
In hepatic impairment:
- Augmentin: Use with caution; monitor liver function 4
- Most cephalosporins: No dose adjustment needed (except ceftriaxone in combined severe hepatic and renal impairment)
In renal impairment: